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We examined a variety of strains of Sindbis virus for the genetic changes responsible for differences in
neurovirulence in mice. SVlA (a low passage of the AR339 strain of Sindbis virus), a neuroadapted Sindbis
virus (NSV), and two laboratory strains of Sindbis virus (HRSP and TotollOl) were examined. NSV causes
severe encephalomyelitis with hind-limb paralysis and high mortality after intracerebral inoculation in
weanling mice. In contrast, SV1A causes only mild, nonfatal disease in weanling mice; however, in suckling
mice, SVlA causes a fatal encephalomyelitis after either intracerebral or subcutaneous inoculation. The two
laboratory strains used have a greatly reduced neurovirulence for suckling mice and are aviruleit for weanling
mice. The nucleotide sequences and encoded amino acid sequences of the structural glycoproteins of these four
strains were compared. Hybrid genomes were constructed by replacing restriction fragments in a full-length
cDNA clone of Sindbis virus, from which infectious RNA can be transcribed in vitro, with fragments froni
cDNA clones of the various strains. These recombinant viruses allowed us to test the importance of each amino
acid difference between the various strains for neurovirulence in weanling and suckling mice. Glycoproteins E2
and El were of paramount importance for neurovirulence in adult mice. Recombinant viruses containing the
nonstructural protein region and the capsid protein region from an avirulent strain and the El and E2
glycoprotein regions from NSV were virulent, although they were less virulent than NSV. Furthermore,
changes in either E2 (His-55 in NSV to Gln in SV1A) or El (Ala-72 in NSV to Val in SVlA and Asp-313 in NSV
to Gly in SVIA) reduced virulence. For virulence in suckling mice, we found that a number of changes in E2
and El can lead to decreased virulence and that in fact, a gradient of virulence exists.
Sindbis virus is the type species of the genus Alphavirus in
the family Togaviridae. It is among the least pathogenic of
the alphaviruses, which include such important pathogens as
eastern, western, and Venezuelan equine encephalitis vi-
ruses (10). In nature, Sindbis virus is transmitted by mos-
quitoes: and its vertebrate hosts are usually birds or mam-
mals (40). The viral genome is a plus-stranded RNA of
11,703 nucleotides. In the virion, it is complexed with capsid
protein C to form an icosahedral nucleocapsid that is sur-
rounded by a lipid bilayer in which two integral membrane
glycoproteins, E2 and El, are embedded (reviewed in refer-
ence 39). Both El and E2 are anchored in the membrane by
a conventional C-terminal hydrophobic anchor, and they are
closely associated with each other as a heterodimer that
probably forms during synthesis of the glycoproteins (27,
30). This heterodimer is believed to be the functional sub-
unit, and three heterodimers are associated to form a trimer-
ic spike in the virus (8). The spike is the structure that binds
to susceptible cells to initiate infection, and it also possesses
neutralizing epitopes.
Sindbis virus infection of mice has been studied as an
experimental model of acute viral encephalitis (9, 13). Wild-
type Sindbis virus (AR339 strain) causes fatal encephalitis in
suckling mice and nonfatal encephalitis in 4-week-old wean-
ling mice (14). A strain of Sindbis virus that is highly lethal
for weanling and adult mice was isolated after six intracere-
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bral (i.c.) passages of an AR339 strain of Sindbis virus,
alternating between suckling and weanling mice (11). This
neuroadapted strain of Sindbis virus (NSV) has been genet-
ically stable after many passages in cell culture. NSV
replicates 10- to 50-fold more efficiently in the brains of mice
than SV1A (a low-passage strain derived from wild-type
Sindbis Virus AR339), and its i.c. 50% lethal dose is 2 to 20
PFU in weanling mice. After i.c. inoculation with NSV,
weanling mice become ruffled, develop kyphoscoliosis and
hind-limb paralysis, and have high mortality (11, 12). Thete
is poliomyelitis, particularly involving the ventrai horns, in
the thoracic and lumbar spinal cord (12). Stanley et al. (35)
demonstrated that some anti-Sindbis virus El and E2 mono-
clonal antibodies discriminate between NSV and SV1A,
suggesting that changes in the surface glycoproteins are
associated with changes in virulence.
Olmsted et al. (20, 21) have selected Sindbis virus variants
in vitro that are attenuated in suckling mice. Thus, strains of
Sindbis virus can be essentially avirulent for mice of all ages,
virulent for suckling mice but avirulent for weanling mice, or
virulent for mice of all ages.
Recently, a complete cDNA clone of Sindbis virus has
been constructed from which infectious RNA can be tran-
scribed in vitro with SP6 RNA polymerase (28). This has
made it possible to map changes among the various strains of
Sindbis virus which lead to differences in virulence in mice,
an approach similar to that used by Kohara et al. (15) to map
virulence determinants in poliovirus.
MATERIALS AND METHODS
Virus stocks and preparation of virus and viral RNA. SV1A
(derived from a low-passage isolate of AR339 obtained from
the American Type Culture Collection, Rockville, Md.) and
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NSV were grown and titers were determined on monolayers
of primary and secondary chicken embryo fibroblasts (CEF),
as previously described (35). Virus was precipitated from the
culture fluid with polyethylene glycol and was purified by
successive velocity sedimentation and equilibrium density
centrifugation (23). The isolation of viral RNA was described
previously (29).
cDNA cloning. cDNA synthesis followed essentially the
procedure of Okayama and Berg (19) as modified by Lind-
qvist et al. (16). A plasmid vector referred to as proteus 1
was tailed with deoxyribosylthymine (40 to 60 residues) and
used as a primer for first-strand cDNA synthesis. Second-
strand synthesis then used Escherichia coli DNA polymer-
ase I, E. coli RNase H, and E. coli DNA ligase. After
second-strand synthesis, the double-stranded DNA was cut
with Hindlll and ligated intramolecularly. The resulting
clones have an insert of 5,438 nucleotides [plus a variable
length of poly(A)] and contain the entire structural protein
coding region of Sindbis virus.
General recombinant DNA techniques. Restriction endonu-
cleases and DNA-modifying enzymes were purchased from
commercial sources and used essentially as recommended
by the manufacturer. Plasmids were grown, purified, and
analyzed by standard methods, with minor modifications
(17).
Construction of hybrid genomes. Hybrid genomes were
produced by replacing restriction fragments in Sindbis virus
clone TotollO1 or Toto5O (28) with the corresponding re-
gions from cDNA clones derived from NSV, with cDNA
from strain SV1A, or with cDNA from a clone of Sindbis
virus HRSP strain (for details of the restriction sites used,
see Fig. 1 and 2). Virus was rescued from these recombinant
clones and tested for its biological properties.
In vitro transcription and RNA transfection. RNA tran-
scripts were synthesized as described elsewhere (28).
Briefly, either supercoiled plasmid templates or plasmid
DNAs which had been digested with an appropriate restric-
tion endonuclease to produce a runoff transcript were tran-
scribed in vitro by SP6 RNA polymerase in a solution
containing 40 mM Tris chloride (pH 7.6); 6 mM MgCI; 2 mM
spermidine; 1 mM each ATP, CTP, GTP, and UTP; 100 p,g
of nuclease-free bovine serum albumin per ml; 5 mM dithio-
threitol; 1 mM m7G(5')ppp(5')G cap analog; 500 U of human
placental RNase inhibitor per ml; 400 U of SP6 polymerase
per ml; and 10 to 100 ,g of template DNA per ml. Quanti-
tation of the RNA transcript was effected by including a
trace amount of [32P]CTP in the reaction and counting a
sample of the product after adsorption to DE81 paper
(Whatman, Inc., Clifton, N.J.). Confluent monolayers of
secondary CEF in 35-mm-diameter tissue culture plates
(about 106 cells) were transfected with the resulting RNA.
After they were washed once with Eagle minimal essential
medium (7) containing Earle salts but not serum, the cells
were incubated with 1.5 ml of Eagle medium containing 50
mM Tris chloride (pH 7.3) at 25°C and 200 ,ug of DEAE
dextran per ml (500,000 average molecular weight; Sigma
Chemical Co.) for 60 min at 37°C. This medium was re-
moved, and 200 ,ul of in vitro-transcribed RNA diluted in
phosphate-buffered saline was added to the cells and incu-
bated at room temperature for 60 min with occasional
rocking. PFU were quantitated by overlaying the monolayer
with 3- ml of 1.2% agarose (SeaKem; FMC Corp., Marine
Colloids Div., Rockland, Maine) in Eagle medium containing
2% fetal calf serum, followed by incubation at 30 or 40°C for
3 or 2 days, respectively. Plaques were visualized by staining
with neutral red. Virus stocks were produced by removing
the transfection mix and incubating the cells in 3 ml of Eagle
medium containing 3% fetal calf serum for 48 h or longer at
300C.
Sequence determination of SV1A and NSV cDNA. DNA
sequencing was carried out on cloned cDNA by the method
of Maxam and Gilbert (18) as modified by Smith and Calvo
(34), using restriction fragments 3' end labeled with the
Klenow fragment of E. coli DNA polymerase (Bethesda
Research Laboratories, Inc., Gaithersburg, Md.). NSV
clones NSV5-37 and NSV5-44 and SV1A clones SV1A-3 and
SV1A-21 were analyzed. Chain termination sequencing of
RNA with reverse transcriptase as described by Ou et al.
(22) and Zimmern and Kaesberg (41), using intracellular viral
RNA as a template and synthetic oligonucleotides as prim-
ers, was also used to obtain part of the sequence. To test
virus derived from hybrid cDNAs for the predicted se-
quence, certain regions of the RNA genome sequence were
confirmed by chain termination sequencing in the same way.
All of the sequencing was obtained on two clones or checked
by the dideoxy sequencing of an RNA template (which gives
the majority nucleotide at any position) to rule out cloning
artifacts and sequencing of minor variants.
Animal tests. Viruses for animal inoculation were grown
and assayed by plaque formation on BHK-21 cells. Three- to
four-week-old BALB/cJ weanling mice of either sex
(Jackson Laboratory, Bar Harbor, Maine) were inoculated
i.c. with 1,000 PFU of virus in 0.03 ml of Hanks balanced salt
solution containing 1% fetal calf serum. One- to three-day-
old CD-1 (ICR) suckling mice (Charles River Breeding
Laboratories, Wilmington, Mass.) were inoculated subcuta-
neously with 500 PFU of virus in each hind limb (footpad).
Mice were observed for 25 days. The percent mortality was
determined for weanling mice, and the percent mortality and
mean day of death were determined for suckling mice. At
least 10 weanling mice and two litters of suckling mice were
inoculated with each virus strain. For recombinant strains,
viruses grown from 2 to 4 different plaques were tested
separately. These data have been pooled for presentation.
For viruses which killed weanling mice at 1,000 PFU, the i.c.
dose for 50% mortality was determined by the method of
Reed and Muench (25), using groups of 10 mice at serial
10-fold dilutions.
RESULTS
Sindbis virus strains. Four strains of Sindbis virus and
recombinants between various strains were used in these
studies (Table 1). The passage history of these strains
significantly affects the interpretation of the results. SV1A is
a low-passage stock (7 to 9 passages in suckling mouse brain)
received from the American Type Culture Collection and
subsequently passaged five times in BHK cells (including
three sequential plaque purifications) and twice in CEF. The
AR339 strain that served as the parent for NSV had a more
extensive passage history. It was obtained originally from H.
Hineberg (Cleveland Metropolitan General Hospital) after
an unknown passage history, and it was subsequently passed
10 times in mouse brain, once in BHK cells, and more than
10 times in CEF before neuroadaption (14). NSV was
obtained from this AR339 strain by serial transmission six
times by i.c. inoculation alternately in suckling and weanling
mice (11). This virus was subsequently passed twice in CEF
to isolate viral RNA for sequence analysis.
In addition, two laboratory strains of Sindbis virus derived
from infectious RNA rescued from cDNA clones (28) were
used; both were derived from the AR339 strain. The first of
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TABLE 1. Sindbis virus strains
Virulence in:
Virus strain" Passage historyb Suckling Weanling
mice mice
SV1A 9 SMB, 5 BHK, 2 CEF + -
NSV Unknown passages in + -F
cell culture, 10 MB,
1 BHK, 10 CEF,
6(SMB + MB),' 2
CEF
TotollO1 Extensive passage in +
cell culture
HRSP Extensive passage in +
cell culture
"All strains were derived by passage of the AR339 strain, isolated originally
from a pool of Culex univittatus in August 1952, in Sindbis, Egypt, by
inoculation into suckling mouse brain (40).
b Number and type of passage. SMB, Suckling mouse brain; MB, mouse
brain; BHK, BHK-21 cells.
Six i.c. inoculations alternately in suckling and weanling mouse brain.
these laboratory variants was rescued from cDNA clone
TotollOl and contains nucleotides 1 to 2713 and 9805 to
11703 from the HRSP strain described below and nucleotides
2714 to 9804 from a strain of uncertain passage history before
cloning as TotollO1. The second strain, from clone TotoSO,
was derived from cDNA made to the HRSP strain of Sindbis
virus (heat-resistant small-plaque strain). The HR strain was
obtained by Burge and Pfefferkorn (5) from AR339 by
selecting variants able to survive heating to'56°C. It had been
subsequently passaged multiple times in both CEF and BHK
cells before isolation of the small-plaque variant (38). HRSP
was then passaged several times in CEF before being cloned
as Toto5O. The sequence of the HRSP strain has been
published previously (28, 37).
Sequence analysis of the glycoproteins of NSV and of SVIA.
Because monoclonal antibodies discriminate between NSV
and SV1A (35) and attenuating mutations have been found in
E2 (6, 21), it seemed likely that the glycoproteins would be
important for neurovirulence in Sindbis virus. We therefore
obtained the nucleotide sequence of the region encoding the
glycoproteins, and from this we deduced the amino acid
sequence of glycoproteins E3, E2, and El for both SV1A
and NSV and cormpared this sequence with that previously
published for HRSP (Fig. 1).
In the nucleotide sequence obtained for the glycoprotein
E3 region, there were no differences among strains SV1A,
NSV, and HRSP. In glycoprotein E2, however, there were
two nucleotide differences between SV1A and NSV, both of
which led to amino acid substitutions. Nucleotide 8795 is A
in SV1A and U in NSV, resulting in a Gln-to-His change at
position 55 of E2. Nucleotide 9255 is G in SV1A and A in
NSV, leading to the replacement of Arg in SV1A by Gly in
NSV at position 209 of E2. Amino acid 55 is Gln in the HRSP
strain (as it is in SV1A), whereas amino acid 209 is Gly in
HRSP (as it is in NSV).
NSV and SV1A differ from HRSP in three additional
amino acids of E2. Position 3 of NSV and SV1A is Thr,
whereas HRSP has Ile at this position. Position 23 of SV1A
and NSV is Glu; it is Val in HRSP (Glu-23 was previously
shown to be the ancestral amino acid in HR [1]). Finally,
position 172 of E2 is Gly in SV1A and NSV and Arg in
HRSP. The changes at positions 3 and 172 may have arisen
during selection of the HR strain.
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FIG. 1. Sequence differences between SV1A (SV), NSV, and
HRSP. At the top is a schematic diagram of the structural region of
the Sindbis virus genome. The positions of a number of restriction
enzyme sites are- shown, as well as the boundaries between the
different proteihs encoded, together with their coordinates num-
bered from the 5' end of the RNA according to Strauss et al. (37). At
the bottom are schematic sequence diagrams of three Sindbis
strains. Nucleotides that differ between any of the strains are shown
above the line (numbered from the 5' end as described above), and
encoded amino acids (if a change in coding is involved) are shown
below the line, using the single-letter amino acid code. The amino
acid numbers refer to the position within the glycoprotein; thus Q55
is residue 55 of glycoprotein E2, etc. The sequence from nucleotide
8571 in E3 to the end of the RNA was determined for SV1A and for
NSV as described in Materials and Methods. The sequence for
HRSP is from the work of Strauss et al. (37). C, Capsid protein; 6K,
polypeptide 6K.
In glycoprotein El, there were six nucleotide differences
between SV1A and NSV which led to two amino acid
changes. Silent changes were found at positions 10392 (C in
SV1A -* U in NSV), 10571 (A -> G), 10748 (C -- tJ), and
10815 (C -* U). The coding changes were at position 10279
(U in SV1A -- C in NSV), which led to the substitution of
Val in SV1A by Ala in NSV at position 72 of El, and at
nucleotide 11002 (G -* A), which led to the substitution of
Gly by Asp at position 313. Position 72 is Ala in HRSP (as it
is in NSV), whereas amino acid 313 is Gly in HRSP (as it is
in SV1A). In addition to differing from each other at these
positions, SViA and NSV also differ in position 237 (Ala)
from HRSP (Ser); this change may also have arisen during
selection of the HR strain.
Of the eight nucleotide differences between SV1A and
NSV, seven were transitions (three C -+ U, three G A,
and one U -> C change). The transversion was the A U
change, which led to the substitution of Gln by His.
There were no changes between SV1A and NSV in the 3'
noncoding region.
Construction of recombinant viruses. To examine the effect
of the different amino acid substitutions on the neurovirul-
ence of Sindbis virus, a number of recombinant viruses were
constructed. To accomplish this, restriction fragments from
clones of SV1A, NSV, or HRSP cDNA were used to replace
the corresponding restriction fragments in clone TotollOl
or, in one case, Toto5O. These clones contain a complete
cDNA copy of Sindbis virus inserted downstream from an
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FIG. 2. Construction of recombinant Sindbis virus genomes in
the glycoprotein region. Restriction fragments in clone TotollOl
(28) were replaced by the corresponding fragments from NSV,
SV1A (SV), or HRSP (derived from TotoSO), as indicated in the
diagram. The restriction sites used and their coordinates in the viral
genome are indicated.
SP6 RNA polymerase promoter from which infectious RNA
can be transcribed in vitro (28). RNA was transcribed from
the recombinant clones and transfected onto CEF cells.
Monolayers were incubated at 30°C under liquid medium to
rescue infectious virus or under agarose at 30 and 40°C for
plaque assays. None of the recombinant viruses was tem-
perature sensitive. The titers of the rescued viruses were
between 108 and 109 PFU/ml. They were passaged once in
BHK cells and then examined for their biological properties.
The constructs tested are illustrated schematically in Fig.
2. The restriction sites used to construct the hybrid genomes
and their coordinates numbered from the 5' end of the RNA
(37) are also shown. The StuI site at position 10770 is not
present in all of the virus strains. Those with Ser at position
237 of El possess this site, whereas those that have Ala at
this position do not. In all cases, the recombinants possess
the nonstructural protein region and the capsid protein
region from TotollOl or from TotoSO and only the glycopro-
tein region or portions of the glycoprotein region are derived
from other strains.
Neurovirulence of recombinant viruses for weanling mice.
The neurovirulence of each of the recombinant viruses, the
TABLE 2. Neurovirulence of Sindbis strains in weanling mice"
Virus strain No. dead/no. tested % Mortality
NSV 21/21 100
TE12 15/35 44
TE 2/55 4
TES 0/20 0
TE2 0/20 0
TE2S 0/30 0
TE1 0/21 0
SV1A 0/20 0
Totol101 0/10 0
TotoSO 0/20 0
" Mice were challenged with 1,000 PFU of virus by i.c. inoculation. At least
two independent stocks were tested, and the results were averaged.
parental viruses (NSV, SV1A, HRSP), and viruses rescued
from TotoSO and TotollOl was tested in 3- to 4-week-old
weanling mice inoculated i.c. with 1,000 PFU of each virus.
In each case, two or more independent virus stocks were
tested. The results were pooled, and the relevant data are
summarized in Table 2.
Only NSV and the recombinant TE12 were virulent for
weanling mice. TE12 has the nucleotide sequence from 8571
to 11552 of NSV and nucleotides 1 to 8570 and 11553 to
11703 from TotollOl, that is, glycoproteins E2 and El from
NSV and the remainder of the genome from TotollOl (Fig.
2). TotollOl is avirulent for weanling mice, whereas TE12 is
virulent, which demonstrates that the envelope proteins
alone are sufficient to confer virulence to an otherwise
avirulent strain. However, TE12 has a higher 50% lethal
dose than NSV (50 versus 3, calculated by the method of
Reed and Muench [25]), and the overall mortality is reduced
(Table 2), which suggests that nucleotide sequences outside
the envelope protein region are also important for neuro-
virulence. These sequences are presumably in the region
encoding the replicase proteins, thereby affecting the effi-
ciency of virus replication, although changes in the capsid
protein or in noncoding regulatory sequences cannot be
ruled out.
All of the other strains are avirulent in weanling mice.
Thus, strains containing only glycoprotein El or only E2
from NSV are avirulent, which demonstrates that changes in
both El and E2 were necessary for the transition in neuro-
virulence from SV1A to NSV.
Neurovirulence of recombinant viruses for suckling mice.
Our major interest in these studies was to define the changes
that led to virus attenuation in weanling mice. However,
Sindbis virus has also been used as a model system for the
study of neurovirulence in suckling mice (6, 20, 21, 24), and
it seemed of interest to compare the virulence of these
constructs in suckling mice as well (Table 3). Strains NSV
and TE12 were essentially indistinguishable in their neuro-
virulence (although the mean day of death may be slightly
higher in studies with TE12). Thus, although TotollO1 is
much less virulent for suckling mice than NSV, possession
of the glycoproteins from NSV is sufficient to render
TotollOl fully virulent for suckling mice. Strains that con-
tain E2 from NSV and El from NSV, SV1A, or TotollOl
were also neurovirulent in suckling mice, causing 100%
mortality after subcutaneous inoculation, as did a construct
containing only the N-terminal domain of E2 from NSV with
the remainder of E2 from HRSP and El from SV1A (con-
struct TES). The survival time of the animals varied from 3
to 5 days, depending on the construct tested. When E2 was
derived from TotollOl (construct TE1 or virus from
(8038) (8571)(8866)
Ncol Stul Ncol
I I I
TE12
TE
TES
TE2
TE2S
TE1101 [
ETE1
TE50
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TABLE 3. Neurovirulence of Sindbis strains in suckling mice"
Virus strainb No. dead! % Mortality MDOD'
no. tested
NSV 31/31 100 3.3
TE 77/77 100 3.6
TE12 20/20 100 3.9
SV1A 20/20 100 4.5
TES 47/47 100 4.8
TE2 20/20 100 5.2
TE2S 31/36 86 8.3
TEllOld 31/44 (70) (9.4)
TE1 27/40 68 9.9
TotollOl 33/66 50 8.1
TotoSO (HRSP) 21/49 43 10.8
TE50d 4/21 (19) (12.8)
" Mice were challenged with 1,000 PFU of virus by subcutaneous inocula-
tion at 1 to 3 days of age.
b Fig. 2. At least two independent stocks were tested, and the results were
averaged.
' MDOD, Mean day of death after subcutaneous injection of 1,000 PFU.
d The neurovirulence of these constructs is dependent on the exact age of
the mice and drops from 100% mortality in 1- to 2-day-old mice to 20%Y in 3-
to 4-day-old mice (see text).
TotollOl) or TotoSO (HRSP strain) the resultant virus was
less virulent. With these strains, 30 to 60% of the inoculated
mice survived and those that died had an extended survival
time. The construct TE50 is discussed below. Thus, there is
a gradient of neurovirulence in suckling mice extending from
a mortality of 100% with a survival time of 3 days to a
mortality of 20 to 40% with a 12-day survival time.
Correlation of amino acid changes with neurovirulence. The
amino acid changes among the various strains of Sindbis
virus in the E2 and El glycoproteins that have been assayed
for neurovirulence have been summarized in Table 4, with
the strains listed in descending order of neurovirulence.
Sequence data for NSV and SV1A and for constructs
containing sequences from these viruses are from Fig. 1; the
TotoSO sequence is the HRSP sequence determined by
Strauss et al. (37), and the data for TotollOl are from the
work of Polo et al. (24) and R. E. Johnston (personal
communication).
For weanling mice, as noted above, changes in both E2
and El contribute to the differences seen between SVlA and
NSV. In E2 the change at position 55 from His (in NSV) to
TABLE 4. Amino acid differences among Sindbis virus strains
Amino acid in glycoprotein at position indicated:
Virus E2 El
strain"
3 23 55 172 209 251 72 75 237 313
NSV T E H G G A A D A D
TE12 T E H G G A A D A D
TE T E H G G A V D A G
SVlA T E Q G R A V D A G
TES T E H R G A V D A G
TE2 T E H G G A A G S G
TE2S T E H R G A A D S G
TEllOl I E Q G G V A G A G
TE1 I E Q G G V A D A D
TotollOl I E Q G G V A G S G
TotoSO I V Q R G A A D S G
TESO I V Q R G A A D A G
" Strains are listed in order of decreasing virulence. The source of the
sequence data for each strain is described in the text.
Gln (in SVlA) appears to be primarily responsible for
attenuation (compare NSV and construct TE12 with SVlA
and construct TE1), although the changes from Thr to Ile at
position 3 and Gly to Arg at position 209 cannot be evaluated
independently from these constructs. In glycoprotein El,
either the change of Ala to Val at position 72 or the change
of Asp to Gly at 313 or both appear to attenuate the virus
(compare NSV and construct TE12 with SVlA and con-
struct TE).
The situation for neurovirulence in suckling mice is more
complex. As noted above, the different strains do not exhibit
an all-or-none effect. Also, it is difficult to exclude cooper-
ative interactions between the different changes found. With
these provisos we can draw a number of conclusions.
Firstly, as indicated above, only changes in glycoproteins El
and E2 lead to virus attenuation in the constructs tested.
Secondly, in glycoprotein E2, Gln-55 appeared to be re-
quired, but not sufficient, for attenuation. Attenuated E2s
also had Ile-3, Arg-172, or Gly-209. The Gly-to-Arg change
at position 172 did lead to a slight increase in survival time
when combined with His-55 (compare TE with TES and
TE2 with TE2S) and could have been involved in attenua-
tion. The Thr-to-Ile change at position 3 could also have
been attenuating, according to the data presented here,
although Polo et al. (24) have argued that it is not involved in
attenuation. The change at position 209 (as well as the
changes at positions 23 and 251) did not appear to be
involved in attenuation. Thirdly, in glycoprotein El, two
changes appear to be important in this group of constructs,
i.e. the Ala-to-Val change at position 72 and the Ala-to-Ser
change at position 237. When TE is compared with TE2 or
TES is compared with TE2S, it is clear that the two changes
together lead to decreased mortality and extended survival.
To separate the two changes in El, the constructs TE1101
and TE50 were made. In initial experiments, TE1101 dem-
onstrated an intermediate virulence, with 70% of the suck-
ling mice dying and the mean day of death at 9.4 days (Table
3). However, the results were variable from litter to litter, in
contrast to the results obtained with other constructs, and it
appeared that the effects of this virus might be more age
dependent. Further experiments to test this possibility re-
vealed that results with TE1101 were, in fact, strongly age
dependent. In 1- to 2-day-old mice, the mortality was 100%
(10 of 10 mice; mean day of death, 5.7). In slightly older mice
(3 to 4 days old), mortality was 20% (2 of 10 mice died, with
a mean day of death of 14.5). Similarly, results with con-
struct TE50 were age dependent in the same way. In 1- to
2-day-old mice, 10 of 10 mice died (mean day of death, 10.2);
in 3- to 4-day-old mice, 2 of 10 died (mean day of death, 10).
TotoSO and TotollOl exhibited no age dependence in similar
experiments with 1- to 2-day-old and 3- to 4-day-old mice.
These results taken together suggest that the Ala-to-Ser
change at position 237 is somewhat attenuating in suckling
mice but that the Ala-to-Val change at position 72 may also
contribute. The Asp-to-Gly change at position 75 does not
appear to make a significant contribution to attenuation in
this system, and the effect of the Asp-to-Gly change at
position 313 is unclear.
DISCUSSION
The AR339 strain of Sindbis virus demonstrates age-
dependent virulence in mice. Mice up to 8 days old develop
acute encephalitis that is fatal; older mice also develop
encephalitis, but the infection is not fatal (14, 26). More virus
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can be isolated from the brain and other tissues of suckling
mice than from older mice. The AR339 strain was originally
isolated by the inoculation of suckling mice and passaged
several times in this host (40), which may have been partially
responsible for the neurovirulent characteristics of the
strain. Starting from AR339, more virulent strains which are
neurovirulent in weanling mice have been isolated by alter-
nate i.c. passage in suckling and weanling mice (11); presum-
ably the passage in weanling mice selected for virus that was
able to replicate better in the central nervous system of older
mice. More attenuated strains of Sindbis virus have also
been obtained from the AR339 strain. Olmsted et al. (20, 21)
have used several selection procedures, including selection
for rapid penetration and growth in vitro, to isolate variants
that were attenuated in suckling mice (see also reference 24).
Barrett and Atkins (2) have shown that temperature-sensi-
tive mutants are often attenuated. The present report and
Polo et al. (24) have also shown that laboratory strains
represented by HRSP (and TotoSO) and TotollOl are atten-
uated for suckling mice. These strains have been maintained
by extensive passage in cell culture, usually in chicken cells
or BHK cells (and the HR strains were selected for the
ability to tolerate high temperatures). The passage of virus in
cell culture is a standard method for selecting attenuated
virus for vaccines and appears in this case also to have
selected variants which are reduced in virulence for mice.
We should note, however, that the virulent properties of
NSV and of SV1A have been maintained upon passage in
cell culture, although an extensive series of passages has not
been tested for its effects.
By constructing recombinant viruses among strains that
differ in virulence, we have mapped a number of virulence
determinants. The situation in weanling mice seems clear-
cut. There are determinants in both glycoproteins E2 and El
that lead to attenuation, and there are determinants in the
nonglycoprotein regions as well. In glycoprotein E2, the
change of His to Gln at position 55 is attenuating, and in
glycoprotein El, the change of Ala-72 to Val and the change
of Asp-313 to Gly lead to attenuation. The results with
suckling mice were more complex. As noted above, it
appears that a spectrum of neurovirulence exists with dif-
ferent virus strains, and in at least some cases the virulence
is sharply age dependent. In addition, changes at multiple
sites appear to have unpredictable effects, and thus the
genetic background of the virus is important. Finally, when
our results are compared with those of Johnston and col-
leagues (6, 20, 21, 24), it also appears that there may be
differences that depend upon the strain of mouse. Although
we have tested a large number of constructs, it would require
testing many more and comparing the changes in different
combinations to completely resolve the ambiguities. How-
ever, our results indicate that His-55 and Gly-172 (and
possibly Thr-3) in E2 and Ala-72 and Ala-237 (and possibly
Asp-313) and El are involved in neurovirulence in suckling
mice (the situation with El is peculiar; one interpretation of
the results is that forms of El virulent for weanling mice are
less virulent for suckling mice and vice versa). Davis et al.
(6) have shown the change from Ser to Arg at position 114 of
E2 is attenuating. The fact that changes in the glycoproteins
can attenuate the virus is consistent with studies of several
other virus systems in which structural proteins have been
implicated as determinants of virulence (3, 4, 31, 32).
The concept of neurovirulence is complex. The efficiency
of replication of the virus in peripheral tissues, the efficiency
of crossing the blood-brain barrier, and the efficiency of
replication in the central nervous system once the virus
invades are all important. There appear to be many ways to
change a virulent virus so that it becomes less virulent.
Changes in the replicase so that the virus replicates less
rapidly may do so. Changes in the glycoproteins may affect
the speed of virus penetration or maturation, thus affecting
the growth rate, or these changes may affect tissue tropism
and thus the ability of the virus to invade certain tissues,
such as the central nervous system.
Our simple hypothesis to explain the results of this study
is that the changes in the surface glycoproteins that lead to
attenuation result in changes in the affinity of the virus for
receptors on uninfected cells, thus altering its cell tropism.
The effect need not be all or none. If altered virus bound to
receptors in certain cells or tissues with reduced affinity or if
the alteration produced virus that bound to a different class
of receptors with variable expression in different tissues, the
alteration in tissue tropism or cell type preferences could be
relative, affecting the kinetics of virus replication in different
organs and allowing host defenses to clear the infection and
prevent death.
It is not known whether the changes in the Sindbis virus
glycoproteins leading to differences in neurovirulence for
mice lead to differences in attachment to cellular receptors.
Smith and Tignor (33) compared the binding of two different
field isolates of Sindbis virus differing in virulence and found
that neuroblastoma cells (N-18) as well as nonneural cells
(CER) had increased numbers of receptors for the virulent
AR86 strain compared with the avirulent AR339 strain.
Distinct receptors for the two strains were postulated on the
basis of sensitivity to enzymatic degradation. Whether the
same would be true for the more closely related strains used
in this study (both derived from AR339) is not known.
Comparative studies of the replication of NSV and SVlA in
the brains and spinal cords of i.c. inoculated weanling mice
have shown that both viruses infect the central nervous
system and that the target cells for replication are the same,
primarily neurons and ependymal cells (A. C. Jackson, T. R.
Moench, B. D. Trapp, and D. E. Griffin, Lab. Invest., in
press). However, more virus is produced and neurons show
greater injury after infection with NSV than SV1A. Further
study is required to determine whether this is due to a
decrease in the effective concentration of receptors for
SVlA, leading to slower spread of the virus, or whether both
SVlA and NSV recognize the same receptors on the same
cells but subsequent steps in NSV replication are more
efficient. The surface glycoproteins of alphaviruses are also
important in other steps of virus replication, such as pene-
tration and fusion with lysosome or phagosome membranes
to release the RNA, and for interaction with the capsid
protein during virion maturation. Many of these steps in-
volve conformational changes in the El-E2 heterodimer
which might be affected by changes in the amino acid
structure of these glycoproteins.
The fact that a variety of changes in El and E2 affect
neurovirulence and the fact that the effects of each change
are different have obvious implications for vaccine develop-
ment. Historically, one of the problems encountered during
virus passage to develop attenuated strains has been overat-
tenuation, so that the vaccine strain is no longer efficacious.
On the other hand, multiple attenuating mutations are desir-
able so that the frequency of reversion to virulence is
negligible. The ability to test the effect of individual attenu-
ating changes and to mix them at will in recombinant strains
in the approach used here could be of great value when
applied to other viruses for which a vaccine is desired.
J. VIROL.
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